Messages from the third International Conference on Clinical Metagenomics (ICCMg3) |
| |
| Authors: | Etienne Ruppé Jacques Schrenzel |
| |
| Affiliation: | 1. AP-HP, Hôpital Bichat-Claude Bernard, Laboratoire de Bactériologie, F-75018, Paris, France;2. INSERM, IAME, UMR 1137, F-75018, Paris, France;3. Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, F-75018, Paris, France;4. Bacteriology and Genomics Research Laboratories, Division of Infectious Diseases, Geneva University Hospitals and Geneva University, 4 rue Gabrielle-Perret-Gentil, 1205, Geneva, Switzerland |
| |
| Abstract: | Clinical metagenomics (CMg), referring to as the application of metagenomic sequencing of clinical samples in order to recover clinically-relevant information, has been rapidly evolving these last years. Following this trend, we held the third International Conference on Clinical Metagenomics (ICCMg3) in Geneva in October 2018. During the two days of the conference, several aspects of CMg were addressed, which we propose to summarize in the present manuscript. During this ICCMg3, we kept on following the progresses achieved worldwide on clinical metagenomics, but also this year in clinical genomics. Besides, the use of metagenomics in cancer diagnostic and management was addressed. Some new challenges have also been raised such as the way to report clinical (meta)genomics output to clinicians and the pivotal place of ethics in this expanding field. |
| |
| Keywords: | Corresponding author. Laboratoire de Bactériologie, Hôpital Bichat-Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France. Fax: +33 140258580. Metagenomics Next-generation sequencing Microbiota Bioinformatics Conference report |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
